183 related articles for article (PubMed ID: 31196778)
1. Predictors of Discontinuation of Long-Acting Reversible Contraception Before 30 Months of Use by Adolescents and Young Women.
Cohen R; Sheeder J; Teal SB
J Adolesc Health; 2019 Aug; 65(2):295-302. PubMed ID: 31196778
[TBL] [Abstract][Full Text] [Related]
2. Free-of-charge long-acting reversible contraception: two-year discontinuation, its risk factors, and reasons.
Saloranta TH; Gyllenberg FK; But A; Gissler M; Laine MK; Heikinheimo O
Am J Obstet Gynecol; 2020 Dec; 223(6):886.e1-886.e17. PubMed ID: 32562657
[TBL] [Abstract][Full Text] [Related]
3. Twelve-month contraceptive continuation and repeat pregnancy among young mothers choosing postdelivery contraceptive implants or postplacental intrauterine devices.
Cohen R; Sheeder J; Arango N; Teal SB; Tocce K
Contraception; 2016 Feb; 93(2):178-83. PubMed ID: 26475368
[TBL] [Abstract][Full Text] [Related]
4. Predictors of contraceptive switching and discontinuation within the first 6 months of use among Highly Effective Reversible Contraceptive Initiative Salt Lake study participants.
Simmons RG; Sanders JN; Geist C; Gawron L; Myers K; Turok DK
Am J Obstet Gynecol; 2019 Apr; 220(4):376.e1-376.e12. PubMed ID: 30576664
[TBL] [Abstract][Full Text] [Related]
5. Continuation rates of long-acting methods of contraception. A comparative study of Norplant implants and intrauterine devices.
Fleming D; Davie J; Glasier A
Contraception; 1998 Jan; 57(1):19-21. PubMed ID: 9554246
[TBL] [Abstract][Full Text] [Related]
6. Factors Associated With Contraceptive Method Choice and Initiation in Adolescents and Young Women.
Cohen R; Sheeder J; Kane M; Teal SB
J Adolesc Health; 2017 Oct; 61(4):454-460. PubMed ID: 28712596
[TBL] [Abstract][Full Text] [Related]
7. Initiation and continuation of long-acting reversible contraception in the United States military healthcare system.
Chiles DP; Roberts TA; Klein DA
Am J Obstet Gynecol; 2016 Sep; 215(3):328.e1-9. PubMed ID: 27005514
[TBL] [Abstract][Full Text] [Related]
8. Perceptions of long-acting reversible contraception among women receiving medication for opioid use disorder in Vermont.
Rey CN; Badger GJ; Melbostad HS; Wachtel D; Sigmon SC; MacAfee LK; Dougherty AK; Heil SH
Contraception; 2020 May; 101(5):333-337. PubMed ID: 32014521
[TBL] [Abstract][Full Text] [Related]
9. Fertility intentions and long-acting reversible contraceptive use among HIV-negative single mothers in Zambia.
Li JL; Kilembe W; Inambao M; Vwalika B; Parker R; Sharkey T; Visoiu AM; Haddad LB; Wall KM; Allen S
Am J Obstet Gynecol; 2020 Apr; 222(4S):S917.e1-S917.e15. PubMed ID: 31953114
[TBL] [Abstract][Full Text] [Related]
10. Long-acting reversible contraceptive acceptability and unintended pregnancy among women presenting for short-acting methods: a randomized patient preference trial.
Hubacher D; Spector H; Monteith C; Chen PL; Hart C
Am J Obstet Gynecol; 2017 Feb; 216(2):101-109. PubMed ID: 27662799
[TBL] [Abstract][Full Text] [Related]
11. Postpartum contraception: initiation and effectiveness in a large universal healthcare system.
Brunson MR; Klein DA; Olsen CH; Weir LF; Roberts TA
Am J Obstet Gynecol; 2017 Jul; 217(1):55.e1-55.e9. PubMed ID: 28257962
[TBL] [Abstract][Full Text] [Related]
12. Adherence to Recommended Practices for Provision of Long-Acting Reversible Contraception Among Providers in a Large U.S. Health Care System.
Judge-Golden CP; Wiesenfeld HC; Chen BA; Borrero S
J Womens Health (Larchmt); 2020 Dec; 29(12):1586-1595. PubMed ID: 32667847
[No Abstract] [Full Text] [Related]
13. Prevalence and predictors of initiation of intrauterine devices and subdermal implants immediately after surgical abortion.
Roe AH; Fortin J; Janiak E; Maurer R; Goldberg AB
Contraception; 2019 Aug; 100(2):89-95. PubMed ID: 31082394
[TBL] [Abstract][Full Text] [Related]
14. Postpartum LARC discontinuation and short interval pregnancies among women with HIV: a retrospective 9-year cohort study in South Carolina.
Lazenby G; Francis E; Brzozowski N; Rucker L; Dempsey A
Contraception; 2019 Oct; 100(4):279-282. PubMed ID: 31226321
[TBL] [Abstract][Full Text] [Related]
15. Choice of the levonorgestrel intrauterine device, etonogestrel implant or depot medroxyprogesterone acetate for contraception after aspiration abortion.
Steinauer JE; Upadhyay UD; Sokoloff A; Harper CC; Diedrich JT; Drey EA
Contraception; 2015 Dec; 92(6):553-9. PubMed ID: 26093190
[TBL] [Abstract][Full Text] [Related]
16. Health Care Provider Attitudes about the Safety of "Quick Start" Initiation of Long-Acting Reversible Contraception for Adolescents.
Morgan IA; Zapata LB; Curtis KM; Whiteman MK
J Pediatr Adolesc Gynecol; 2019 Aug; 32(4):402-408. PubMed ID: 30731216
[TBL] [Abstract][Full Text] [Related]
17. Differences in Contraceptive Discontinuation Among Black and White Women: Evidence from the Contraceptive CHOICE Project.
Allsworth JE; Secura GM; Ajibade OO; Peipert JF
J Womens Health (Larchmt); 2018 May; 27(5):599-606. PubMed ID: 29768114
[TBL] [Abstract][Full Text] [Related]
18. Acceptability of an experimental intracervical device: results of a study controlling for selection bias.
Shain RN; Ratsula K; Toivonen J; Lähteenmäki P; Luukkainen T; Holden AE; Rosenthal M
Contraception; 1989 Jan; 39(1):73-84. PubMed ID: 2491982
[TBL] [Abstract][Full Text] [Related]
19. Long-acting reversible contraception in adolescents: a systematic review and meta-analysis.
Diedrich JT; Klein DA; Peipert JF
Am J Obstet Gynecol; 2017 Apr; 216(4):364.e1-364.e12. PubMed ID: 28038902
[TBL] [Abstract][Full Text] [Related]
20. Characteristics associated with discontinuation of long-acting reversible contraception within the first 6 months of use.
Grunloh DS; Casner T; Secura GM; Peipert JF; Madden T
Obstet Gynecol; 2013 Dec; 122(6):1214-21. PubMed ID: 24201685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
